All the Drug Class Drugs
Intrauterine Device. Levonorgestrel 13.5 mg. IUS: 1 Releasing 14mcg/24h 24 days after
inser., 10mcg/24h 60days after inser.,
6mcg/24h 1 year after inser. 6mcg/24h 3
years after inser. See lit.
Contracep. for up to 3 yrs.
C/I: Preg. Acute/recurrent pelvic inflam.
dis. or condit. assoc. with incr. risk for
pelvic infec. Acute cervicitis or vaginitis;
Postpart. endometritis or infec. abortion
during the past three mths. Cervical
intraepithelial neoplasia until resolved.
Uterine or cervical malignancy.
Progestogen-sens. tumours, e.g. breast
cancer. Abnor. vaginal bleed. of unknown
etiology; Congenital or acquired uterine
anomaly includ. fibroids which would
interfere with inser. and / or retention of
the intrauterine syst. (i.e. if they distort the
uterine cavity); Acute liver dis. or liver
tumour; Hypersens.
Intrauterine Device. Levonorgestrel 19.5 mg. IUS: 1. 1 unit in uterine cavity. See lit.
Contracep. for up to 5 yrs.
C/I: Hypersens. to act. ingr. Preg. Pts. with current/recurent PID. Pts. with increased susceptibil. to pelvic infect. Pts. with vag./ cervc. infec. Postprt. infect. Pts. who experienced abortion/miscarriage in past 3 mnths. Pts. with cell abnormalit. in the cervix. Pts. with suspected of cervic./uterus cancer, breast cancer. Pts. with uterine bleed. Pts. with cervical/uterus fibrosis. Pts. active liver dis. or liver tumour.
